Publication: Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study
cris.virtual.author-orcid | 0000-0001-5297-6062 | |
cris.virtualsource.author-orcid | 91a3060c-0e74-4217-944d-3471766e2083 | |
datacite.rights | open.access | |
dc.contributor.author | Rauch, Andri | |
dc.contributor.author | Nolan, D | |
dc.contributor.author | Martin, A | |
dc.contributor.author | McKinnon, E | |
dc.contributor.author | Almeida, C | |
dc.contributor.author | Mallal, Simon | |
dc.date.accessioned | 2024-10-13T13:37:58Z | |
dc.date.available | 2024-10-13T13:37:58Z | |
dc.date.issued | 2006 | |
dc.description.abstract | Abacavir therapy is associated with significant drug hypersensitivity in approximately 8% of recipients, with retrospective studies indicating a strong genetic association with the HLA-B*5701 allele. In this prospective study, involving 260 abacavir-naive individuals (7.7% of whom were positive for HLA-B*5701), we confirm the usefulness of genetic risk stratification, with no cases of abacavir hypersensitivity among 148 HLA-B*5701-negative recipients. | |
dc.description.numberOfPages | 4 | |
dc.description.sponsorship | Universitätsklinik für Infektiologie | |
dc.identifier.doi | 10.7892/boris.19240 | |
dc.identifier.isi | 000238030000015 | |
dc.identifier.pmid | 16758424 | |
dc.identifier.publisherDOI | 10.1086/504874 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/93006 | |
dc.language.iso | en | |
dc.publisher | The University of Chicago Press | |
dc.publisher.place | Cary, N.C. | |
dc.relation.isbn | 16758424 | |
dc.relation.ispartof | Clinical infectious diseases | |
dc.relation.issn | 1058-4838 | |
dc.relation.organization | DCD5A442BB13E17DE0405C82790C4DE2 | |
dc.title | Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.endPage | 102 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 99 | |
oaire.citation.volume | 43 | |
oairecerif.author.affiliation | Universitätsklinik für Infektiologie | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2019-10-31 14:16:50 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 19240 | |
unibe.journal.abbrevTitle | CLIN INFECT DIS | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- 43-1-99.pdf
- Size:
- 98.57 KB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- publisher
- Content:
- published